Sinovac Expands Production Capacity
At the site, Sinovac Beijing is expecting to manufacture the enterovirus 71 (EV71) vaccine, which causes hand, foot and mouth disease (HFMD), and its other currently marketed flu
The US Food and Drug Administration (FDA) has expanded the approved indication for Bristol Myers Squibb’s (BMS) Camzyos (mavacamten) to treat symptomatic obstructive hypertrophic cardiomyopathy (oHCM) in adults and paediatric patients weighing at least 30kg (66lb).
Stefan Verheye, department of cardiology at Middelheim Hospital, Antwerp, said: “These clinical results suggest very promising benefits for patients. We had already demonstrated that the self-expanding and disconnectable